[go: up one dir, main page]

MY118379A - Therapeutic agents. - Google Patents

Therapeutic agents.

Info

Publication number
MY118379A
MY118379A MYPI9802556A MY118379A MY 118379 A MY118379 A MY 118379A MY PI9802556 A MYPI9802556 A MY PI9802556A MY 118379 A MY118379 A MY 118379A
Authority
MY
Malaysia
Prior art keywords
ibuprofen
aqueous
active ingredient
water
composition
Prior art date
Application number
Inventor
Jeffrey Dickinson
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Priority to MYPI9802556 priority Critical patent/MY118379A/en
Publication of MY118379A publication Critical patent/MY118379A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

AN IBUPROFEN COMPOSITION YIELDING AN AQUEOUS PREPARATION HAVING A PH OF LESS THAN 7 ON THE ADDITION OF WATER TO SAID COMPOSITION WHICH COMPRISES ONE OR MORE MEDICAMENTS INCLUDING AN IBUPROFEN MEDICAMENT WHICH FORMS AN IBUPROFEN ACTIVE INGREDIENT HAVING A MELTING POINT LESS THAN 100°C, WHEN COMBINED WITH WATER TO GIVE AN AQUEOUS PREPERATION HAVING A PH OF LESS THAN 7 AND PHOSPHOLIPID MATERIAL INTIMATELY MIXED WITH THE IBUPROFEN MEDICAMENT. THE PHOSPHOLIPID MATERIAL IS CAPABLE OF FORMING AN AQUEOUS PREPARATION COMPRISING AN AMULSION OR DISPERSION COMPRISING AN AQUEOUS PHASE SUBSTANTIALLY FREE OF SAID IBUPROFEN ACTIVE INGREDIENT AND A DISCRETE PHASE CONSISTING ESSENTIALLY OF SAID PHOSPHOLIPID MATERIAL AND INSOLUBLE PHARMACOLOGICALLY ACTIVE INGREDIENT INCLUDING SAID IBUPROFEN INGREDIENT ON THE ADDITION OF WATER TO SAID COMPOSITION. THE INVENTION ALSO PROVIDES AQUEOUS DRINK PREPARATIONS (ESPECIALLY HEATED EMULSIONS) PRODUCED THEREFROM AND A PROCESS TO PREPARE SAID AQUEOUS DRINK PREPARATIONS.
MYPI9802556 1998-06-09 1998-06-09 Therapeutic agents. MY118379A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI9802556 MY118379A (en) 1998-06-09 1998-06-09 Therapeutic agents.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI9802556 MY118379A (en) 1998-06-09 1998-06-09 Therapeutic agents.

Publications (1)

Publication Number Publication Date
MY118379A true MY118379A (en) 2004-10-30

Family

ID=47225768

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI9802556 MY118379A (en) 1998-06-09 1998-06-09 Therapeutic agents.

Country Status (1)

Country Link
MY (1) MY118379A (en)

Similar Documents

Publication Publication Date Title
CA2274773A1 (en) Aqueous therapeutic agents of ibuprofen
GEP20043314B (en) Pharmaceutical Composition Comprising Entacapone, Levodopa, and Carbidopa
AU5084299A (en) Sustained release pharmaceutical preparation
WO2000007979A3 (en) Compounds and compositions for delivering active agents
WO2001095899A8 (en) Pharmaceutical compositions comprising cannabidiol derivatives
WO2002036732A3 (en) Active variants of fgf with improved specificity
AU677279B2 (en) Application of carbamazepine and oxcarbazepine in the treatment of Parkinson's disease and Parkinsonian syndromes
WO1996040057A3 (en) Reverse fluorocarbon emulsion compositions for drug delivery
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
ATE198152T1 (en) ORAL MEDICINAL PREPARATION WITH DELAYED RELEASE OF ACTIVE INGREDIENTS
NO306894B1 (en) Use of galanthamine for the preparation of a pharmaceutical formulation for the treatment of nicotine addiction
EP0682942A4 (en) Novel, percutaneously absorbable preparation.
CA2287534A1 (en) Biodegradable microparticles for the sustained delivery of therapeutic drugs
UA66812C2 (en) Drug formulation with controlled release of active ingredient
GB9424766D0 (en) Pharmaceutical composition
GB2328872B (en) Method for preparing pharmaceutical formulations
WO2001041747A3 (en) Pharmaceutical preparation containing cytostatic agents and electron acceptors for treating cancer
CA2285985A1 (en) A method for preparing aqueous liposomal compositions comprising an active ingredient which is highly insoluble in water
MY118379A (en) Therapeutic agents.
GEP20043377B (en) Pharmaceutical Complex
EP0815851A3 (en) Method of reducing irritativeness of surface active agents and aqueous compositions with reduced irritativeness
WO1999043299A3 (en) Oral formulation for hydrophilic drugs
WO2002006299A3 (en) Therapeutic uses for aminosterol compounds
WO1998033478A3 (en) Rna- and dna-based active agents in nanoparticles
WO2002036105A3 (en) Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders